Training in vaccine development: combined glycoconjugate vaccine against meningococcus a,c, w135,y

Project Information

CONJUVAC

Grant agreement ID: QLK2-CT-2001-60005

Project closed

Start date 10 October 2001

End date 9 October 2003

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 174 768,00

EU contribution € 174 768,00

Coordinated by

CHIRON S.R.L.
Italy

Objective

The present training project will be aimed to develop glycoconjugate molecules against meningococcus group A, W135 and y and eventually to combine them with our anti meningococcus C conjugate vaccine to form a tetravalent anti- meningococcal vaccine effective in infants.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

You need to log in or register to use this function

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Call for proposal

Data not available

Funding Scheme

BUR - Bursaries, grants, fellowships

Coordinator

CHIRON S.R.L.

• EU contribution: No data
• Address: Via Fiorentina 1 ; 53100 SIENA ; Italy
• Total cost: No data